Strategic support services FDA office of the commissioner patient engagement project in FDA's medical products centers to generate an action plan and an implementation plan to enhance patient…
Ended Awarded Last action
- Contract number
- HHSF223201610239W
- Awardee
-
The Mitre Corporation UEI DMHDNDCPWUD1
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $1,189,907
Award facts
- Opportunity
-
- RFPCMS20110021 Solicitation number
- Centers for Medicare & Medicaid Services sponsored Federally Funded Research and Development Center Award Notice · Posted Mar 17, 2011
- Contract value 100% obligated
- $1,189,907.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- West McLean, VA 22102, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $1,189,907 |
About this award
This federal contract award was issued by the Food and Drug Administration (FDA) to The Mitre Corporation, a non-profit organization that operates federally funded research and development centers (FFRDCs). The $1,189,907 cost-plus-fixed-fee contract is for the FDA's Office of the Commissioner to engage Mitre in providing strategic support services for a patient engagement project in the FDA's medical products centers. The goal is to generate an action plan and implementation roadmap to enhance patient engagement. As part of this effort, Mitre has subcontracted with McKinsey & Company, a global management consulting firm, to assist with the landscape analysis, coordination of patient engagement, and development of the implementation plan. This contract does not have a set-aside designation, reflecting Mitre's status as a large, non-profit organization. The contract supports the FDA's efforts to improve patient engagement and participation in the development and regulation of medical products.
Description
Strategic support services FDA office of the commissioner patient engagement project in FDA's medical products centers to generate an action plan and an implementation plan to enhance patient engagement.
Quick answers
Who was awarded contract HHSF223201610239W?
HHSF223201610239W was awarded to The Mitre Corporation by Food and Drug Administration (Department of Health and Human Services) on September 27, 2016.
How much is contract HHSF223201610239W worth?
The government has obligated $1,189,907 on HHSF223201610239W.
Is contract HHSF223201610239W an order under another contract?
Yes. HHSF223201610239W is a delivery order under HHSM500201200008I, an indefinite delivery contract.
Was contract HHSF223201610239W competed?
The extent of competition for HHSF223201610239W was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award